TNFRSF11B and Peri-Implantitis: Using the level of osteoprotegerin (OPG) as a bone marker to assess implant prognosis has been reported in previous studies, showing a higher concentration of OPG levels in healthy peri-implant tissue than those in cases of peri-implantitis [9,10].